Zydus Lifesciences informs about disclosure

28 Mar 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a disclosure in prescribed Form ‘C’ under regulation 7(2) of Insider Trading Regulations, received from Zydus Family Trust, Promoter of the Company with respect to sale of 5,83,000 Equity Shares of Re 1 each in the open market. The said sale is to enable the Company to comply with the requirements of minimum public shareholding as mandated under rule 19(2)(b) and 19(A) of Securities Contracts (Regulation) Rules, 1957 and regulation 38 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

948.20 -2.75 (-0.29%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.